Caribou Biosciences Company
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
Investors
Headquarters:
Berkeley, California, United States
Industry:
Biotechnology, Health Care, Therapeutics
Employee Number:
101-250
Estimated Revenue:
$10M to $50M
Investors Number:
28
Investment Stage:
N/A
Investor Type:
Late Stage Venture
Funding Status:
Late Stage Venture
Number Of Exists:
1
Technology:
Others
Last Funding Type:
Series C
Founded Date:
2011
Total Funding:
167549904
Last Funding Date:
2021